Skip to content

Form 4 filed by SMITH TODD N

SMITH TODD N filed this Form 4 on Latigo Biotherapeutics, Inc. with 1 transaction row and 0 holding rows, accepted by EDGAR 2026-11-18 21:24:56 UTC.

Accession
0001523672-26-000010
Filed
2026-11-18
Accepted by EDGAR
Ingested
Source
EDGAR live feed

Original filing

Issuer and reporting owners

Issuer: Latigo Biotherapeutics, Inc. (CIK 2056611)

Rows

SecurityDateCodeSharesPriceOwned afterOwnership
Employee Stock Option (right to buy) derivative2026-11-15A granted+2,207,516$02,207,516D